Obviousness-type Double Patenting (ODP): From In re Zickendraht to In re Cellect and Beyond
In this webinar, Dr. Ricardo Moran will discuss “Obviousness-type Double Patenting (ODP) – From In re Zickendraht to In re Cellect and Beyond.” This presentation will focus on laying a solid foundation for understanding ODP rejections, how they arise, how best to handle them, and the ramifications downstream (e.g., during litigation) of actions taken during prosecution.
Dr. Moran’s practice focuses on chemical and pharmaceutical intellectual property law, including pharmaceutical patent litigation; preparation and prosecution of patent applications; infringement, validity, patentability, and due diligence analyses and opinions; and counseling of clients. Ricardo earned his B.S. in chemistry from Allegheny College; his M.S. in organic chemistry from Emory University; his Ph.D. from the University of Maryland, College Park; and his law degree from the American University Washington College of Law. After receiving his Ph.D., he worked as a post-doctoral fellow at the Pennsylvania State University.
Principal Nicholas Lanzatella, J.D., Ph.D., will moderate.
Click here to download presentation materials: SLW Life Sciences Webinar 3 – ODP.